SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial
DENVER, Jan. 22, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary...
Day: January 22, 2025
Clearside Biomedical Announces its Asia-Pacific Partner, Arctic Vision, Received Approval of Suprachoroidal Treatment for Uveitic Macular Edema in Australia and Singapore
- ARCATUS®, Branded as XIPERE® in the U.S., is the First Globally Approved Suprachoroidal Therapy - - Continued Global Expansion...
IVOS Medical Receives Phase II SBIR Award from the National Institutes of Health for $1.9M
IRVINE, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) -- IVOS Medical, Inc., a startup medical device specializing company in airway management,...
IVOS Medical Announces BOSS G4™ Video Laryngoscope Sheath Designed to Improve Intubation Safety in High-Risk Patients
Innovative Device Provides Clear Vision, Maintains Continuous Oxygen Delivery, and Clears Aspirate and Debris During IntubationIRVINE, Calif., Jan. 22, 2025...
Kamada Announces a $25 Million 3-Year Contract for Supply of KAMRAB® and VARIZIG® in Latin America
REHOVOT, Israel and HOBOKEN, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical...
Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple Sclerosis from the PoNS® Therapeutic Experience Program Study
--PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy on gait deficit improvement in people...
Nurix Therapeutics Announces Appointment of John Northcott as Chief Commercial Officer
Mr. Northcott brings over 20 years of biopharmaceutical experience building commercial organizations and successfully commercializing novel products, including BTK inhibitor...
OKYO Pharma Receives $1.4 Million in Non-Dilutive Funding
LONDON and NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing...
Coherus Presents Final Phase 2 Clinical Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025
– Casdozokitug, in combination with atezolizumab/bevacizumab, final data demonstrate durability of response and improvement in depth of response including a...
Axsome Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18
NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era...
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2024
Company Announcement Net sales of DARZALEX® in 2024 totaled USD 11,670 millionGenmab receives royalties on worldwide net sales from Johnson...
Greenwich LifeSciences Provides Update on Commercial Manufacturing
STAFFORD, Texas, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused...
Coloplast A/S – Q1 2024/25 Earnings Release – Invitation to conference call on 4 February 2025 at 11.00am CET (correction)
Tuesday, 4 February 2025 at 11.00 - 12.00am CET (corrected from 10.00 - 11.00am CET in an earlier version of...
Panakeia to present results of blinded multi-site validation of its AI-driven molecular profiling tool for colon cancer, PANProfiler Colon, at ASCO GI Symposium
PANProfiler Colon achieved 92.69% positive and 94.05% negative agreement for MSI/dMMR detection Real-world blinded validation on 3178 colorectal cancer patient samplesData...
ENA Respiratory Successfully Completes Phase Ib Dosing of Antiviral Host Defense Immune Enhancer INNA-051 Dry Powder Formulation in Older Adults and Advances Study in Young Adults
New intranasal formulation with significantly improved stability was well-tolerated and led to local activation of innate immune pathways in adults...
New survey shows most Canadians overlook their liver health, yet 1 in 4 is affected by liver disease
TORONTO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Only nine per cent of Canadians prioritize their liver when thinking about their...
Smartee Unveils Eco Initiatives at New 100,000 sqm Clear Aligner Factory
SHANGHAI, Jan. 22, 2025 /PRNewswire/ -- Sustainability meets innovation as Smartee Denti-Technology announces the launch of its 100,000 sqm clear aligner...
Empowered with Meg Ryan to Feature Liberty House Recovery Center in New Segment on Empowering Individuals to Overcome Addiction
FORT LAUDERDALE, Fla., Jan. 22, 2025 /PRNewswire/ -- The distinguished and high-profile program Empowered, hosted by Meg Ryan, is proud...
2025 Japan Prize Laureates Announced
TOKYO, Jan. 22, 2025 /PRNewswire/ -- The Japan Prize Foundation announced the winners of the 2025 Japan prize on January...
JelloX Aims to Improve Patient-Centered Care with AI-powered 3D Digital Pathology
First shared at a recent Japanese Society of Digital Pathology meeting, the company is forging a global alliance with a...